Osteopontin, a protein with cytokine-like properties, is associated with inflammation in Crohn's disease

Scandinavian Journal of Immunology

Volumn 65, Issue 5, 2007, Pages 453-460

  Agnholt, J ^a   Kelsen, J ^a   Schack, L ^b   Hvas, C L ^a   Dahlerup, J F ^a   Sorensen E S ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CD69 ANTIGEN; GAMMA INTERFERON; INFLIXIMAB; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; MESALAZINE; MYCOPHENOLIC ACID; OSTEOPONTIN; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BLOOD SAMPLING; COLON BIOPSY; CONTROLLED STUDY; CROHN DISEASE; DOSE RESPONSE; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; INTESTINE CELL; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; ANTIBODIES, MONOCLONAL; CELLS, CULTURED; CROHN DISEASE; CYTOKINES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-10; MALE; MIDDLE AGED; OSTEOPONTIN; T-LYMPHOCYTES;

EID: 34247343353     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2007.01908.x     Document Type: Article

References (25)

1. O'Regan AW, Nau GJ, Chupp GL, Berman JS. Osteopontin (Eta-1) in cell-mediated immunity: teaching an old dog new tricks. Immunol Today 2000 21 : 475 8.
2. O'Regan AW, Hayden JM, Berman JS. Osteopontin augments CD3-mediated interferon-gamma and CD40 ligand expression by T cells, which results in IL-12 production from peripheral blood mononuclear cells. J Leukoc Biol 2000 68 : 495 502.
3. Ashkar S, Weber GF, Panoutsakopoulou V, Sanchirico ME, Jansson M, Zawaideh S et al. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 2000 287 : 860 4.
4. Bayless KJ, Meininger GA, Scholtz JM, Davis GE. Osteopontin is a ligand for the alpha(4)beta(1) integrin. J Cell Sci 1998 111 : 1165 74.
5. O'Regan AW, Chupp GL, Lowry JA, Goetschkes M, Mulligan N, Berman JS. Osteopontin is associated with T cells in sarcoid granulomas and has T cell adhesive and cytokine-like properties in vitro. J Immunol 1999 162 : 1024 31.
6. O'Regan A, Berman JS. Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation. Int J Exp Pathol 2000 81 : 373 90.
7. Nau GJ, Chupp GL, Emile JF, Jouanguy E, Berman JS, Casanova JL et al. Osteopontin expression correlates with clinical outcome in patients with mycobacterial infection. Am J Pathol 2000 157 : 37 42.
8. Duchmann R, Kaiser I, Hermann E, Mayet W, Ewe K, Meyer zum Buschenfelde KH. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD) [see comments]. Clin Exp Immunol 1995 102 : 448 55.
9. Fiocchi C. From immune activation to gut tissue injury: the pieces of the puzzle are coming together [editorial; comment]. Gastroenterology 1999 117 : 1238 41.
10. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998 115 : 182 205.
11. Qu-Hong, Brown LF, Dvorak HF, Dvorak AM. Ultrastructural immunogold localization of osteopontin in human gastric mucosa. J Histochem Cytochem 1997 45 : 21 33.
12. Gassler N, Autschbach F, Gauer S, Bohn J, Sido B, Otto HF et al. Expression of osteopontin (Eta-1) in Crohn disease of the terminal ileum. Scand J Gastroenterol 2002 37 : 1286 95.
13. Sato T, Nakai T, Tamura S, Okamoto S, Matsuoka K, Sakuraba A et al. Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune response. Gut 54, 1254 62. 17-8-2005.
14. Masuda H, Takahashi Y, Asai S, Takayama T. Distinct gene expression of osteopontin in patients with ulcerative colitis. J Surg Res 2003 111 : 85 90.
15. Masuda H, Takahashi Y, Asai S, Hemmi A, Takayama T. Osteopontin expression in ulcerative colitis is distinctly different from that in Crohn's disease and diverticulitis. J Gastroenterol 2005 40 : 409 13.
16. Da Silva AP, Pollett A, Rittling SR, Denhardt DT, Sodek J, Zohar R. Exacerbated tissue destruction in DSS-induced acute colitis of OPN-null mice is associated with downregulation of TNF-alpha expression and non-programmed cell death. J Cell Physiol 2006 208 : 629 39.
17. Mary JY, Modigliani R. Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID). Gut 1989 30 : 983 9.
18. Best WR, Becktel JM, Singleton JW, Kern Jr. F, Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976 70 : 439 44.
19. Agnholt J, Kaltoft K. In situ activated intestinal T cells expanded in vitro - without addition of antigen - produce IFN-gamma and IL-10 and preserve their function during growth. Exp Clin Immunogenet 2001 18 : 213 25.
20. Sorensen ES, Petersen TE. Purification and characterization of three proteins isolated from the proteose peptone fraction of bovine milk. J Dairy Res 1993 60 : 189 97.
21. Sorensen ES, Hojrup P, Petersen TE. Posttranslational modifications of bovine osteopontin: identification of twenty-eight phosphorylation and three O-glycosylation sites. Protein Sci 1995 4 : 2040 9.
22. Agnholt J, Dahlerup JF, Buntzen S, Tottrup A, Nielsen SL, Lundorf E. Response, relapse and mucosal immune regulation after infliximab treatment in fistulating Crohn's disease. Alimentary Pharmacol Ther 2003 17 : 703 10.
23. Autschbach F, Braunstein J, Helmke B, Zuna I, Schurmann G, Niemir ZI et al. In situ expression of interleukin-10 in noninflamed human gut and in inflammatory bowel disease. Am J Pathol 1998 153 : 121 30.
24. Braunstein J, Qiao L, Autschbach F, Schurmann G, Meuer S. T cells of the human intestinal lamina propria are high producers of interleukin-10 [see comments]. Gut 1997 41 : 215 20.
25. Sodek J, Batista Da Silva AP, Zohar R. Osteopontin and mucosal protection. J Dent Res 2006 85 : 404 15.